estriol has been researched along with Abnormalities, Autosome in 53 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the efficacy of a screening protocol using a combination of maternal age plus three biochemical markers--maternal serum alpha-fetoprotein (MSAFP), hCG, and unconjugated estriol (E3)--for the antenatal detection of fetal Down syndrome." | 7.68 | A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. ( Cheng, EY; Hickok, DE; Lieppman, RE; Luthy, DA; Williams, MA; Zebelman, AM, 1993) |
| "Between November, 2011 and October, 2013, a total of 25 520 pregnant women (15-20+6 gestational weeks) underwent a screening test of triple serum markers including free beta-human chorionic gonadotrophin (free βhCG), alpha-fetoprotein (AFP), and unconjugated estriol (µE3) during the second semester of pregnancy." | 3.81 | [Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome]. ( Jiang, J; Liu, J; Tao, H; Wang, J; Wu, J; Yang, L; Zhao, L, 2015) |
| "Second trimester serum levels of alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated estriol were compared for 306 CHD cases and 1224 no-CHD controls drawn from a sample of singleton pregnancies without chromosomal or neural tube defects (NTDs)." | 3.77 | Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects. ( Baer, R; Currier, RJ; Jelliffe-Pawlowski, L; Moon-Grady, AJ, 2011) |
| " They all underwent first trimester combined nuchal translucency (NT), pregnancy-associated plasma protein-A (PAPP-A), and free beta-human chorionic gonadotrophin (f-betahCG), followed by second trimester measurement of unconjugated estriol (uE3), human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP)." | 3.73 | The best marker combination using the integrated screening test approach for detecting various chromosomal aneuploidies. ( Grinshpun-Cohen, J; Herman, A; Itzhaky, D; Maymon, R; Reish, O; Sharony, R, 2005) |
| ", trisomy 21 and other abnormalities) in women receiving prenatal chromosome analysis after a Down syndrome screen-positive result by maternal serum triple-marker testing (alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol analyses)." | 3.69 | Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome. ( Benn, PA; Briganti, S; Greenstein, RM; Horne, D, 1995) |
| " In each pregnancy levels of human chorionic gonadotropin and unconjugated estriol were consistent with the number of continuing gestations." | 3.69 | Maternal serum analyte levels after first-trimester multifetal pregnancy reduction. ( Cervetti, TA; Phillips, OP; Shulman, LP, 1996) |
| "Information on maternal age and maternal serum alpha-fetoprotein, unconjugated oestriol (uE3), and human chorionic gonadotrophin (hCG) levels was used to investigate retrospectively the effect of estimating Edward's syndrome risk in women having multi-marker screening for Down's syndrome." | 3.68 | Expanding multiple marker screening for Down's syndrome to include Edward's syndrome. ( Barkai, G; Chaki, R; Cuckle, H; Goldman, B; Ries, L; Zer, T, 1993) |
| "To test the efficacy of a screening protocol using a combination of maternal age plus three biochemical markers--maternal serum alpha-fetoprotein (MSAFP), hCG, and unconjugated estriol (E3)--for the antenatal detection of fetal Down syndrome." | 3.68 | A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. ( Cheng, EY; Hickok, DE; Lieppman, RE; Luthy, DA; Williams, MA; Zebelman, AM, 1993) |
| "Six cases of trisomy 18 and one case of Turner syndrome were identified by karyotype." | 2.67 | Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. ( Canick, JA; Haddow, JE; Knight, GJ; Palomaki, GE; Panizza, DS; Saller, DN, 1992) |
| "The DR and SPR for trisomy 21 (N = 827) during the quadruple-marker time period were 75." | 1.37 | Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. ( Currier, RJ; Flessel, M; Goldman, S; Hennigan, C; Hodgkinson, C; Kazerouni, NN; Lorey, F; Malm, L; Roberson, M; Tempelis, C, 2011) |
| "In total, 62% of fetuses with cystic hygroma had abnormal chromosome complements and 80% had a poor outcome." | 1.34 | Cystic hygroma and mid-trimester maternal serum screening. ( Celentano, C; Guanciali-Franchi, PE; Iezzi, I; Liberati, M; Palka, C; Prefumo, F; Rotmensch, S, 2007) |
| "Ten fetal chromosomal abnormalities were detected with maternal serum screening." | 1.32 | [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives]. ( Alvarez-Nava, F; Martínez, MC; Morales, A; Padrón, T; Prieto, M; Rojas de Atencio, A; Soto, M; Villalobos, D, 2003) |
| "Three non-Down syndrome chromosomal abnormalities and two Down syndrome mosaic cases would be missed by this approach." | 1.31 | A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%. ( Amiel, A; Ben-Tovim, T; Fejgin, MD; Kaneti, H; Kedar, I; Petel, Y; Rosen, DJ; Tohar, M, 2002) |
| "Two patients had additional fetal anomalies detected on ultrasonography and had abnormal karyotypes, 1 with trisomy 21 and 1 with trisomy 18." | 1.30 | Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography? ( Giudice, T; Sullivan, A; Thiagarajah, S; Vavelidis, F, 1999) |
| "Follow-up of all cases of chromosome abnormalities and severe foetal malformations identified pre- or postnatally has been carried out." | 1.30 | [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience]. ( Christiansen, M; Larsen, LA; Nørgaard-Pedersen, B; Permin, M; Petersen, PL, 1999) |
| "Missed aneuploidies included trisomy 21, sex chromosome abnormalities, trisomy 13, trisomy 22, and trisomy 18." | 1.29 | Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old. ( Boots, L; Desai, R; DuBard, MB; Owen, J; Wenstrom, KD, 1995) |
| "One case of trisomy 21, one case of trisomy 18 and two open neural tube defects showed false negative results." | 1.29 | [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study]. ( Kistner, G; Voss, P; Zwahr, C, 1994) |
| "Gross malformations and hydrops fetalis were detected in 15 and 5 fetuses, respectively." | 1.29 | An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers. ( Balci, S; Beksaç, MS; Cakar, AN; Durak, B; Karakaş, U; Laleli, Y; Ozkan, O, 1995) |
| "Four trisomy 18 pregnancies had UE3 levels less than 0." | 1.29 | Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. ( Aitken, DA; Connor, JM; Crossley, JA, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (26.42) | 18.7374 |
| 1990's | 26 (49.06) | 18.2507 |
| 2000's | 9 (16.98) | 29.6817 |
| 2010's | 4 (7.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, L | 1 |
| Zhao, L | 1 |
| Jiang, J | 1 |
| Liu, J | 1 |
| Tao, H | 1 |
| Wang, J | 1 |
| Wu, J | 1 |
| Jelliffe-Pawlowski, L | 1 |
| Baer, R | 1 |
| Moon-Grady, AJ | 1 |
| Currier, RJ | 2 |
| Kazerouni, NN | 1 |
| Flessel, M | 1 |
| Goldman, S | 1 |
| Hennigan, C | 1 |
| Hodgkinson, C | 1 |
| Lorey, F | 1 |
| Malm, L | 1 |
| Tempelis, C | 1 |
| Roberson, M | 1 |
| Peled, Y | 1 |
| Melamed, N | 1 |
| Krissi, H | 1 |
| Eitan, R | 1 |
| Yogev, Y | 1 |
| Pardo, J | 1 |
| Graf, MD | 1 |
| Gill, P | 1 |
| Krew, M | 1 |
| Schwartz, S | 1 |
| Chitayat, D | 1 |
| Farrell, SA | 1 |
| Huang, T | 1 |
| Meier, C | 1 |
| Wyatt, PR | 1 |
| Summers, AM | 1 |
| DOWLING, RH | 1 |
| KNOX, SJ | 1 |
| JOSSO, N | 1 |
| DE GROUCHY, J | 1 |
| AUVERT, J | 1 |
| NEZELOF, C | 1 |
| JAYLE, MF | 1 |
| MOULLEC, J | 1 |
| FREZAL, J | 1 |
| DE CASAUBON, A | 1 |
| LAMY, M | 1 |
| Chandra, S | 1 |
| Crane, J | 1 |
| Hutchens, D | 1 |
| Bennett, K | 1 |
| O'Grady, T | 1 |
| Duff, A | 1 |
| Macgregor, D | 1 |
| Alvarez-Nava, F | 1 |
| Soto, M | 1 |
| Padrón, T | 1 |
| Morales, A | 1 |
| Villalobos, D | 1 |
| Rojas de Atencio, A | 1 |
| Prieto, M | 1 |
| Martínez, MC | 1 |
| Maymon, R | 1 |
| Sharony, R | 1 |
| Grinshpun-Cohen, J | 1 |
| Itzhaky, D | 1 |
| Herman, A | 1 |
| Reish, O | 1 |
| Celentano, C | 1 |
| Prefumo, F | 1 |
| Iezzi, I | 1 |
| Guanciali-Franchi, PE | 1 |
| Palka, C | 1 |
| Liberati, M | 1 |
| Rotmensch, S | 1 |
| Nielsen, J | 1 |
| Hansen, KB | 1 |
| Sillesen, I | 1 |
| Videbech, P | 1 |
| Wenstrom, KD | 1 |
| Desai, R | 1 |
| Owen, J | 1 |
| DuBard, MB | 1 |
| Boots, L | 1 |
| Holzgreve, W | 1 |
| Miny, P | 1 |
| Schloo, R | 1 |
| Tercanli, S | 1 |
| Barkai, G | 1 |
| Goldman, B | 1 |
| Ries, L | 1 |
| Chaki, R | 1 |
| Zer, T | 1 |
| Cuckle, H | 2 |
| Schmidt, D | 1 |
| Shaffer, LG | 1 |
| McCaskill, C | 1 |
| Rose, E | 1 |
| Greenberg, F | 1 |
| Goodburn, SF | 1 |
| Yates, JR | 1 |
| Raggatt, PR | 1 |
| Carr, C | 1 |
| Ferguson-Smith, ME | 1 |
| Kershaw, AJ | 1 |
| Milton, PJ | 1 |
| Ferguson-Smith, MA | 1 |
| Zwahr, C | 1 |
| Voss, P | 1 |
| Kistner, G | 1 |
| Norton, ME | 1 |
| Kellner, LH | 1 |
| Weiss, RR | 1 |
| Weiner, Z | 1 |
| Neuer, M | 1 |
| Martin, GM | 1 |
| Schulman, H | 1 |
| Lipper, S | 1 |
| Benn, PA | 1 |
| Horne, D | 1 |
| Briganti, S | 1 |
| Greenstein, RM | 1 |
| Beksaç, MS | 1 |
| Durak, B | 1 |
| Ozkan, O | 1 |
| Cakar, AN | 1 |
| Balci, S | 1 |
| Karakaş, U | 1 |
| Laleli, Y | 1 |
| Cheng, EY | 1 |
| Luthy, DA | 1 |
| Zebelman, AM | 1 |
| Williams, MA | 1 |
| Lieppman, RE | 1 |
| Hickok, DE | 1 |
| Hecher, K | 1 |
| Snijders, R | 1 |
| Nicolaides, K | 1 |
| Crossley, JA | 1 |
| Aitken, DA | 1 |
| Connor, JM | 1 |
| Crandall, BF | 1 |
| Hanson, FW | 1 |
| Keener, S | 1 |
| Matsumoto, M | 1 |
| Miller, W | 1 |
| Rose, NC | 1 |
| Mennuti, MT | 1 |
| Mennuti, M | 1 |
| Yankowitz, J | 1 |
| Howser, DM | 1 |
| Ely, JW | 1 |
| Shulman, LP | 1 |
| Phillips, OP | 1 |
| Cervetti, TA | 1 |
| Ross, HL | 1 |
| Elias, S | 1 |
| Sullivan, A | 1 |
| Giudice, T | 1 |
| Vavelidis, F | 1 |
| Thiagarajah, S | 1 |
| Christiansen, M | 1 |
| Petersen, PL | 1 |
| Permin, M | 1 |
| Larsen, LA | 1 |
| Nørgaard-Pedersen, B | 1 |
| Kucerová, M | 1 |
| Horácek, J | 1 |
| Addar, MH | 1 |
| Hogge, WA | 1 |
| Fraer, L | 1 |
| Melegari, T | 1 |
| Rosen, DJ | 1 |
| Kedar, I | 1 |
| Amiel, A | 1 |
| Ben-Tovim, T | 1 |
| Petel, Y | 1 |
| Kaneti, H | 1 |
| Tohar, M | 1 |
| Fejgin, MD | 1 |
| Fabro, S | 1 |
| Schwarz, RH | 1 |
| Palomaki, GE | 2 |
| Knight, GJ | 2 |
| Haddow, JE | 2 |
| Canick, JA | 2 |
| Saller, DN | 2 |
| Panizza, DS | 1 |
| Williams, J | 1 |
| Pulkkinen, A | 1 |
| Bowers, GB | 1 |
| Mason, G | 1 |
| Linton, G | 1 |
| Holding, S | 1 |
| Zolotukhina, TV | 1 |
| Kuznetsov, MI | 1 |
| Kostiuk, EV | 1 |
| Shilova, NV | 1 |
| Solonichenko, VG | 1 |
| Petit, P | 1 |
| Engels, J | 1 |
| Blumenthal, I | 1 |
| Variend, MS | 1 |
| Golubev, VA | 1 |
| Burns, JK | 1 |
| Barrelet, V | 1 |
| Wilson, E | 1 |
| Weihs, D | 1 |
| Cruz, J | 1 |
| Abdul-Karim, RW | 1 |
| Beydoun, SN | 1 |
| Rajendran, KG | 1 |
| Ghosh, SN | 1 |
| Seshadri, R | 1 |
| Bagli, NP | 1 |
| Shah, PN | 1 |
| Gitsch, E | 1 |
| Horger, EO | 1 |
| Hutchinson, DL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Prediction Of Preterm Delivery By Measurement Of Maternal Serum Markers[NCT01009723] | 2,000 participants (Anticipated) | Observational | 2010-03-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for estriol and Abnormalities, Autosome
| Article | Year |
|---|---|
[Maternal serum screening for detection of fetal chromosome abnormalities].
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Down Syndr | 1995 |
Biochemical and ultrasound screening for chromosomal abnormalities.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Congenital Abnormalities; | 1994 |
Screening for fetal chromosomal abnormalities by maternal serum biochemistry and ultrasound examination of fetal morphology.
Topics: alpha-Fetoproteins; Antigens, Tumor-Associated, Carbohydrate; Biomarkers; Chorionic Gonadotropin; Ch | 1993 |
Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Estriol; F | 1993 |
Maternal serum screening for fetal genetic disorders.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Estriol; F | 1997 |
New trends in prenatal screening for chromosomal abnormalities.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Estriol; F | 2000 |
Amniocentesis.
Topics: Abortion, Therapeutic; Amniocentesis; Amniotic Fluid; Bilirubin; Blood Transfusion, Intrauterine; Ch | 1975 |
[The clinical value of amniotic fluid studies (literature review)].
Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Amniocentesis; Amniotic Fluid; Carbon Dioxide; Chr | 1971 |
Some hormonal and genetic aspects of human breast cancer--a review.
Topics: 17-Hydroxycorticosteroids; Adrenalectomy; Adult; Androgens; Breast Neoplasms; Chromosome Aberrations | 1973 |
1 trial available for estriol and Abnormalities, Autosome
| Article | Year |
|---|---|
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Chr | 1992 |
43 other studies available for estriol and Abnormalities, Autosome
| Article | Year |
|---|---|
[Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome].
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosome Aberrations; | 2015 |
Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; Estriol; Fema | 2011 |
Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009.
Topics: Adult; alpha-Fetoproteins; Biomarkers; California; Chorionic Gonadotropin; Chromosome Aberrations; C | 2011 |
The impact of severe hyperemesis gravidarum on the triple test screening results.
Topics: Adult; alpha-Fetoproteins; Blood Chemical Analysis; Case-Control Studies; Chorionic Gonadotropin; Ch | 2012 |
Prenatal detection of structural abnormalities of chromosome 18: associations with interphase fluorescence in situ hybridization (FISH) and maternal serum screening.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Amniotic Fluid; Chorionic Gonadotropin; Chromosome Aberrat | 2002 |
Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes.
Topics: alpha-Fetoproteins; Case-Control Studies; Chorionic Gonadotropin; Chromosome Aberrations; Congenital | 2002 |
TRANSVESTISM AND FERTILITY IN A CHROMOSOMAL MOSAIC.
Topics: Adrenal Cortex Hormones; Androsterone; Blood Group Antigens; Chromosome Aberrations; Chromosome Diso | 1963 |
TRUE HERMAPHRODITISM WITH XX-XY MOSAICISM, PROBABLY DUE TO DOUBLE FERTILIZATION OF THE OVUM.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Blood Group Antigens; Chromosome Aberrations; Chromosome | 1965 |
Maternal serum screening: practice patterns of physicians in Newfoundland.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Estriol; Family Practice; | 2003 |
[Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; C | 2003 |
The best marker combination using the integrated screening test approach for detecting various chromosomal aneuploidies.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosome Aberr | 2005 |
Cystic hygroma and mid-trimester maternal serum screening.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; Estriol; Fema | 2007 |
Chromosome abnormalities in newborn children. Aetiological aspects.
Topics: Chromosome Aberrations; Chromosome Disorders; Estriol; Female; Humans; Infant, Newborn; Male; Matern | 1982 |
Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosome | 1995 |
Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1993 |
Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1994 |
Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Down Syndrome; Estriol; F | 1994 |
[Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study].
Topics: Adolescent; Adult; alpha-Fetoproteins; Anencephaly; Chorionic Gonadotropin; Chromosome Aberrations; | 1994 |
The advantages of using triple-marker screening for chromosomal abnormalities.
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Di | 1995 |
Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Dow | 1995 |
An artificial intelligent diagnostic system with neural networks to determine genetical disorders and fetal health by using maternal serum markers.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; C | 1995 |
A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1993 |
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
Topics: alpha-Fetoproteins; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 18; Down | 1993 |
Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Down Syndr | 1993 |
A 35-year-old pregnant woman considering maternal serum screening and amniocentesis.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chorionic Villi Sampli | 1996 |
Differences in practice patterns between obstetricians and family physicians: use of serum screening.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Estriol; Family Practice; Female | 1996 |
Maternal serum analyte levels after first-trimester multifetal pregnancy reduction.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Estriol; F | 1996 |
Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Choroid Plexus; Chromosome Aberrations; Congenital Abnor | 1999 |
[Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Di | 1999 |
[Biochemical screening in the second trimester of pregnancy from a genetic aspect].
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Dow | 1999 |
Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosomes, Human, Pair | 2001 |
A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Down Syndr | 2002 |
Antepartum evaluation of the high-risk fetus: problems and prospects.
Topics: alpha-Fetoproteins; Amniocentesis; Amniotic Fluid; Birth Weight; Chromosome Aberrations; Chromosome | 1976 |
Prenatal screening for Down's syndrome with use of maternal serum markers.
Topics: Adolescent; Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chromosome | 1992 |
Low maternal serum human chorionic gonadotrophin and unconjugated oestriol in a triploidy pregnancy.
Topics: Abortion, Therapeutic; Adult; Chorionic Gonadotropin; Chorionic Villi Sampling; Chromosome Aberratio | 1992 |
[Detection of chromosomal abnormalities using cordocentesis].
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Chr | 1991 |
Low maternal oestriol excretion and congenital chromosome abnormalities.
Topics: Adult; Chromosome Aberrations; Chromosome Disorders; Estriol; Female; Gestational Age; Humans; Pregn | 1972 |
Maternal urinary oestriol excretion and fetal chromosome abnormalities.
Topics: Adult; Chromosome Aberrations; Chromosome Disorders; Estriol; Female; Fetal Diseases; Humans; Matern | 1972 |
Proceedings: Examination of chromosomes following addition of hormones to human leucocyte cultures.
Topics: Cells, Cultured; Chromosome Aberrations; Chromosomes; Dehydroepiandrosterone; Estriol; Follicle Stim | 1974 |
[Amniocentesis indications and diagnostics].
Topics: Amniocentesis; Amniotic Fluid; Bilirubin; Chromosome Aberrations; Chromosome Disorders; Creatinine; | 1974 |
Amniotic fluid: the value of prenatal analysis. II.
Topics: Abortion, Spontaneous; Adrenal Cortex Hormones; Amniocentesis; Amnion; Amniotic Fluid; Antibodies, A | 1972 |
[The development of gynecology today].
Topics: Austria; Chromosome Aberrations; Chromosome Disorders; Estriol; Female; Genital Diseases, Female; Ge | 1968 |
Diagnostic use of amniotic fluid.
Topics: Abortion, Therapeutic; Acid-Base Equilibrium; Amniotic Fluid; Asphyxia; Bilirubin; Chromosome Aberra | 1969 |